Primerica price target raised to $300 from $275 at Truist

Truist raised the firm’s price target on Primerica to $300 from $275 and keeps a Buy rating on the shares. The analyst cites the company’s Q2 earnings beat while also raising the firm’s FY24 EPS estimate to $18.00 from $17.65 and its FY25 forecast to $20.05 from $19.80 thanks to Primerica’s strong topline trends in Investment and Savings Products segment and the shuttering of the Senior Health operation.